SRR1334717
GTEX
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- GTEX
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- GTEX
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- PANCREAS_BETA_CELLS+0.314
- HEDGEHOG_SIGNALING+0.208
- SPERMATOGENESIS+0.188
- KRAS_SIGNALING_DN+0.173
- PEROXISOME-0.078
- APICAL_SURFACE-0.079
- WNT_BETA_CATENIN_SIGNALING-0.117
- BILE_ACID_METABOLISM-0.128
- APICAL_JUNCTION-0.152
- MYOGENESIS-0.160
Top 10 suppressed
- MYC_TARGETS_V1-0.520
- G2M_CHECKPOINT-0.480
- IL6_JAK_STAT3_SIGNALING-0.471
- E2F_TARGETS-0.461
- TNFA_SIGNALING_VIA_NFKB-0.459
- ANGIOGENESIS-0.448
- MYC_TARGETS_V2-0.400
- ANDROGEN_RESPONSE-0.398
- TGF_BETA_SIGNALING-0.394
- COMPLEMENT-0.392
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1321183 | GTEX | — | 0.968 |
| 2 | SRR661179 | GTEX | — | 0.967 |
| 3 | SRR1478032 | GTEX | — | 0.966 |
| 4 | SRR1443713 | GTEX | — | 0.961 |
| 5 | SRR4195666 | — | — | 0.951 |
| 6 | MNG700 | — | — | 0.945 |
| 7 | BS_3P20Q2C3 | low-grade glioma | — | 0.940 |
| 8 | BS_90B22NGP | ATRT | — | 0.939 |
| 9 | SRR1311182 | GTEX | — | 0.939 |
| 10 | SRR1797231 | — | cohortSC | 0.937 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 4 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| PANCREAS_BETA_CELLS | 0.314 | Cobimetinib | — uncovered |
| HEDGEHOG_SIGNALING | 0.208 | Inavolisib | — uncovered |
| SPERMATOGENESIS | 0.188 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.173 | Remibrutinib | — uncovered |